Buyback (167)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces the live activities schedule for the Offer to Buy (Buyback) acquisition window for Jagsonpal Pharmaceuticals Ltd, running from … | |||||||||||||||
BSE announces the live activities schedule for the Offer to Buy (Buyback) acquisition window for Jagsonpal Pharmaceuticals Ltd, running from 8th May 2026 to 14th May 2026, with an offer price of Rs. 250 per share for up to 16,00,000 equity shares.
| |||||||||||||||
BSE announces the opening of a tender offer buyback window for Jagsonpal Pharmaceuticals Limited, offering to repurchase up to 16,00,000 … | |||||||||||||||
BSE announces the opening of a tender offer buyback window for Jagsonpal Pharmaceuticals Limited, offering to repurchase up to 16,00,000 equity shares at Rs.250 per share for an aggregate consideration not exceeding Rs.40 crores.
| |||||||||||||||
BSE/ICCL announces the settlement calendar for the Offer to Buy – Acquisition Window (Buyback) for Jagsonpal Pharmaceuticals Limited, with … | |||||||||||||||
BSE/ICCL announces the settlement calendar for the Offer to Buy – Acquisition Window (Buyback) for Jagsonpal Pharmaceuticals Limited, with bidding open from May 8 to May 14, 2026 and settlement on May 21, 2026.
| |||||||||||||||
NSE announces EMA Partners India Limited's buyback offer of up to 7,25,000 equity shares at Rs. 100 per share via web-based bidding platform … | |||||||||||||||
NSE announces EMA Partners India Limited's buyback offer of up to 7,25,000 equity shares at Rs. 100 per share via web-based bidding platform from May 7-13, 2026.
| |||||||||||||||
NSE Clearing Limited announces the settlement calendar for the buyback offer under tender offer scheme by EMA Partners India Limited, with … | |||||||||||||||
NSE Clearing Limited announces the settlement calendar for the buyback offer under tender offer scheme by EMA Partners India Limited, with trading window from May 7-13, 2026 and settlement on May 20, 2026.
| |||||||||||||||
BSE announces the Offer to Buy (Buyback) acquisition window schedule for Windlas Biotech Ltd, open from April 30 to May 7, 2026, at Rs. 1000 … | |||||||||||||||
BSE announces the Offer to Buy (Buyback) acquisition window schedule for Windlas Biotech Ltd, open from April 30 to May 7, 2026, at Rs. 1000 per share for up to 4,70,000 equity shares.
| |||||||||||||||
BSE/ICCL notice detailing the settlement schedule for the Offer to Buy acquisition window under the buyback program for Windlas Biotech … | |||||||||||||||
BSE/ICCL notice detailing the settlement schedule for the Offer to Buy acquisition window under the buyback program for Windlas Biotech Limited.
| |||||||||||||||
BSE notifies opening of the tender offer buyback window for Windlas Biotech Limited, allowing eligible shareholders to tender up to 4,70,000 … | |||||||||||||||
BSE notifies opening of the tender offer buyback window for Windlas Biotech Limited, allowing eligible shareholders to tender up to 4,70,000 equity shares at INR 1,000 per share from April 30 to May 7, 2026.
| |||||||||||||||
BSE announces the Offer to Buy (Buyback) acquisition window schedule for Aurobindo Pharma Ltd (AUROPHARMA), open from April 23 to April 29, … | |||||||||||||||
BSE announces the Offer to Buy (Buyback) acquisition window schedule for Aurobindo Pharma Ltd (AUROPHARMA), open from April 23 to April 29, 2026, at an offer price of Rs. 1475 per share for up to 54,23,728 equity shares.
| |||||||||||||||
BSE notifies opening of buyback offer by Aurobindo Pharma Limited to repurchase up to 54,23,728 equity shares at Rs.1,475 per share via … | |||||||||||||||
BSE notifies opening of buyback offer by Aurobindo Pharma Limited to repurchase up to 54,23,728 equity shares at Rs.1,475 per share via tender offer route, aggregating up to Rs.800 crore, open from April 23 to April 29, 2026.
| |||||||||||||||